NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE | EP | Reference Standards | EDQM | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE
EDQM

PharmaCompass Sponsored Ads

Contact Supplier

Naloxone Hydrochloride

Contact Supplier

xyz-pharma-m-2025-04-21

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

With Fermion, start the journey of your innovative API.

Contact Supplier

xyz-pharma-m-2025-04-14

Contact Supplier

NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

40 API Suppliers, 13 USDMF, 12 CEP/COS, 1 JDMF, 2 EU WC, 3 KDMF, 18 NDC API, 18 Listed Suppliers, $ API Reference Price

40 API Suppliers
13 USDMF
12 CEP/COS
1 JDMF
2 EU WC
3 KDMF
18 NDC API
18 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

72 Drugs in Development

72 Drugs in Development

INTERMEDIATES

10 Intermediate Suppliers

10 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

318 FDF Dossiers, 163 FDA Orange Book, 83 Europe, 15 Canada, 14 Australia, 11 South Africa, 32 Listed Dossiers

318 FDF Dossiers
163 FDA Orange Book
83 Europe
15 Canada
14 Australia
11 South Africa
32 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FILM;BUCCAL - EQ 2.1MG BASE;EQ 0.3MG BASE, FILM;BUCCAL - EQ 4.2MG BASE;EQ 0.7MG BASE, FILM;BUCCAL - EQ 6.3MG BASE;EQ 1MG BASE, SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - 0.4MG/0.4ML (0.4MG/0.4ML), TABLET;SUBLINGUAL - EQ 2MG BASE;EQ 0.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;SUBLINGUAL - EQ 8MG BASE;EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - 2MG/0.4ML (2MG/0.4ML), FILM;BUCCAL, SUBLINGUAL - EQ 12MG BASE;EQ 3MG BASE, FILM;BUCCAL, SUBLINGUAL - EQ 2MG BASE;EQ 0.5MG BASE, FILM;BUCCAL, SUBLINGUAL - EQ 4MG BASE;EQ 1MG BASE, FILM;BUCCAL, SUBLINGUAL - EQ 8MG BASE;EQ 2MG BASE

FILM;BUCCAL - EQ 2.1MG BASE;EQ 0.3MG BASE
FILM;BUCCAL - EQ 4.2MG BASE;EQ 0.7MG BASE
FILM;BUCCAL - EQ 6.3MG BASE;EQ 1MG BASE
SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - 0.4MG/0.4ML (0.4MG/0.4ML)
TABLET;SUBLINGUAL - EQ 2MG BASE;EQ 0.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;SUBLINGUAL - EQ 8MG BASE;EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - 2MG/0.4ML (2MG/0.4ML)
FILM;BUCCAL, SUBLINGUAL - EQ 12MG BASE;EQ 3MG BASE
FILM;BUCCAL, SUBLINGUAL - EQ 2MG BASE;EQ 0.5MG BASE
FILM;BUCCAL, SUBLINGUAL - EQ 4MG BASE;EQ 1MG BASE
FILM;BUCCAL, SUBLINGUAL - EQ 8MG BASE;EQ 2MG BASE

RELATED EXCIPIENT COMPANIES

1 Minakem, 4 Rochem International Inc, 18 SPI Pharma, 3 DKSH, 1 Pharm-RX Chemical, 7 Faran Shimi Pharmaceutical, 3 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 8 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 Pramukh Pharmachem, 1 Zeal MediPharma, 1 ACG Worldwide, 10 Actylis, 1 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 16 BASF, 1 Bioplus Life Sciences, 10 Corel Pharma Chem, 6 DFE Pharma, 2 Finar, 7 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 37 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 7 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 23 Roquette, 7 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 Silverline Chemicals, 1 Symrise, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

80 Fillers, Diluents & Binders, 45 Coating Systems & Additives, 32 Direct Compression, 26 Taste Masking, 25 Thickeners and Stabilizers, 24 Controlled & Modified Release, 23 Disintegrants & Superdisintegrants, 23 Granulation, 18 Chewable & Orodispersible Aids, 18 Lubricants & Glidants, 17 Co-Processed Excipients, 9 Parenteral, 9 Solubilizers, 9 Topical, 7 Film Formers & Plasticizers, 5 Empty Capsules, 5 API Stability Enhancers, 5 Rheology Modifiers, 4 Vegetarian Capsules, 4 Emulsifying Agents, 2 Coloring Agents, 1 Surfactant & Foaming Agents

80 Fillers, Diluents & Binders
45 Coating Systems & Additives
32 Direct Compression
26 Taste Masking
25 Thickeners and Stabilizers
24 Controlled & Modified Release
23 Disintegrants & Superdisintegrants
23 Granulation
18 Chewable & Orodispersible Aids
18 Lubricants & Glidants
17 Co-Processed Excipients
9 Parenteral
9 Solubilizers
9 Topical
7 Film Formers & Plasticizers
5 Empty Capsules
5 API Stability Enhancers
5 Rheology Modifiers
4 Vegetarian Capsules
4 Emulsifying Agents
2 Coloring Agents
1 Surfactant & Foaming Agents

DIGITAL CONTENT

244 News #PharmaBuzz

244 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 76 Regulatory FDF Prices

2 US Medicaid Prescriptions
76 Regulatory FDF Prices

MARKET PLACE

18 APIs, 10 FDF Dossiers

18 APIs
10 FDF Dossiers

PATENTS & EXCLUSIVITIES

155 US Patents, 2 US Exclusivities

155 US Patents
2 US Exclusivities

REF. STANDARDS & IMPURITIES

3 EDQM, 5 Others

3 EDQM
5 Others

$ API Ref.Price (USD/KG) : 10,350 Xls

Filters

Reset all filters

Filters

FILTER :

filter Order Code Reset all filters

3 All

01 1N0075000

02 1Y0000695

03 1Y0001571

filter CAS Number Reset all filters

3 All

01 251481-60-8

02 1n/a

filter Reference Standard Reset all filters

3 All

01 1Naloxone for peak identification

02 1Naloxone hydrochloride dihydrate

03 1Naloxone impurity D

Veranova Naloxone hydrochloride

Product Main Page

01

EDQM, Council of Europe

Naloxone for peak identification

AACR Annual meeting

Not Confirmed

01

EDQM, Council of Europe

AACR Annual meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Naloxone for peak identification

CAS Number : 51481-60-8

Quantity Per Vial : 5.1 mg

Sale Unit : 1

Order Code : Y0000695

Batch No : 3

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

EDQM, Council of Europe

Naloxone impurity D

AACR Annual meeting

Not Confirmed

02

EDQM, Council of Europe

AACR Annual meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Naloxone impurity D

CAS Number : n/a

Quantity Per Vial : 25 mg

Sale Unit : 1

Order Code : Y0001571

Batch No : 2

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

EDQM, Council of Europe

Naloxone hydrochloride dihydrate

AACR Annual meeting

Not Confirmed

03

EDQM, Council of Europe

AACR Annual meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Naloxone hydrochloride dihydrate

CAS Number : 51481-60-8

Quantity Per Vial : 100 mg

Sale Unit : 1

Order Code : N0075000

Batch No : 3

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!